EBV BZLF1 (190-197) is an immunodominant peptide derived from the Epstein-Barr virus (EBV) that specifically targets CD8+ T cells. It stimulates the release of interferon-gamma (IFNg), initiating cytotoxic T lymphocyte (CTL) responses. This peptide exhibits cross-reactivity with similar sequences from both host self-proteins and bacterial proteins, making it valuable for studying autoimmune diseases and the immune response to viral infections.
EBV BZLF1 (190-197) is an immunodominant peptide derived from the Epstein-Barr virus (EBV) that specifically targets CD8+ T cells. It stimulates the release of interferon-gamma (IFNg), initiating cytotoxic T lymphocyte (CTL) responses. This peptide exhibits cross-reactivity with similar sequences from both host self-proteins and bacterial proteins, making it valuable for studying autoimmune diseases and the immune response to viral infections.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: